A detailed history of Armistice Capital, LLC transactions in Neuro Pace Inc stock. As of the latest transaction made, Armistice Capital, LLC holds 1,153,614 shares of NPCE stock, worth $10.5 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares
1,153,614
Previous 592,614 94.67%
Holding current value
$10.5 Million
Previous $6.63 Million 113.8%
% of portfolio
0.22%
Previous 0.09%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2025

May 15, 2025

BUY
$10.04 - $14.94 $5.63 Million - $8.38 Million
561,000 Added 94.67%
1,153,614 $14.2 Million
Q4 2024

Feb 14, 2025

BUY
$5.9 - $11.93 $664,422 - $1.34 Million
112,614 Added 23.46%
592,614 $6.63 Million
Q3 2024

Nov 14, 2024

BUY
$6.65 - $8.46 $3.19 Million - $4.06 Million
480,000 New
480,000 $3.35 Million

Others Institutions Holding NPCE

About NeuroPace Inc


  • Ticker NPCE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,846,900
  • Market Cap $226M
  • Description
  • NeuroPace, Inc. operates as a medical device company in the United States. It develops and sells RNS system, a brain-responsive neuromodulation system for treating medically refractory focal epilepsy by delivering personalized real-time treatment at the seizure source. The company's RNS system also records continuous brain activity data; and ena...
More about NPCE
Track This Portfolio

Track Armistice Capital, LLC Portfolio

Follow Armistice Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Armistice Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Armistice Capital, LLC with notifications on news.